Skip to main content
LMND
NYSE Finance

Lemonade Tops Q3 Revenue Estimates and Reiterates First Positive Adjusted EBITDA in Q4

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Positive
Importance info
8
Price
$48.44
Mkt Cap
$3.553B
52W Low
$39.6
52W High
$99.9
52W Position info
22% above low
Off High info
52% below high
Rel. Volume info
1.9× avg
Market data snapshot near publication time

LMND sits 22% above its 52-week low of $39.6 on elevated volume (1.9× avg).

Summary

Lemonade posted Q3 revenue of $336.1M (up 73%, ahead of the ~$322.7M consensus) and reiterated its first positive Adjusted EBITDA quarter of $5-$9M for Q4 2026, while raising full-year GEP and revenue guidance. Gross loss ratio worsened to 65% from 62%.


Key Events · Earnings and Guidance · LMND

  • Q3 Revenue Beats, Up 73%

    Revenue of $336.1M grew 73% from $194.5M a year ago and came in above the ~$322.7M consensus; gross profit rose 48% to a record $118.1M.

  • First Positive Adjusted EBITDA Reiterated

    Guidance calls for Q4 2026 Adjusted EBITDA of $5-$9M — the first positive quarter — with FY 2026 Adjusted EBITDA loss narrowing to ($51)-($47)M from ($113.5)M in the first nine months.

  • Full-Year GEP and Revenue Guidance Raised

    FY 2026 GEP guidance lifted to $1,382-$1,386M and revenue to $1,231-$1,235M; FY IFP reiterated at $1,632-$1,639M, up 34% growth to $1,550.8M in Q3.

  • Loss Ratio Deteriorates

    Gross loss ratio rose to 65% from 62% a year ago, with attritional at 60% and the Europe segment at 104%; net loss widened to $43.7M from $37.5M.


Analysis · LMND · Finance

Revenue of $336.1M grew 73% and beat the ~$322.7M consensus, but guidance is the bigger story: management reiterated positive Adjusted EBITDA of $5-$9M for Q4 2026 — the first profitable quarter in company history — and raised full-year GEP and revenue guidance. That milestone has been promised since 2022, so hitting it removes the main bear case on the stock. The offset is underwriting: gross loss ratio climbed to 65% from 62% a year ago, with the Europe book at 104%, and the net loss widened to $43.7M from $37.5M on higher stock comp and interest expense. Cash and investments of ~$1.2B against $231.6M of borrowings leaves ample runway.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, LMND was trading at $48.44 on NYSE in the Finance sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $39.60 to $99.90. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LMND - Latest Insights

LMND
Nov 05, 2026, 10:31 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $42.64
Real-time Price: $37.84 info
Change: -$4.80 (-11%) info
Market Cap: $2.978B info
LMND
Nov 05, 2026, 7:19 AM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $47.64
Real-time Price: $37.84 info
Change: -$9.80 (-21%) info
Market Cap: $2.978B info
LMND
Nov 05, 2026, 6:05 AM EST
Source: Reuters
Importance Score:
8
Price at Filing: $48.44
Real-time Price: $37.84 info
Change: -$10.60 (-22%) info
Market Cap: $2.978B info
LMND
Jul 30, 2026, 8:51 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $48.26
Real-time Price: $37.84 info
Change: -$10.42 (-22%) info
Market Cap: $2.978B info
LMND
Jul 29, 2026, 6:17 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $57.00
Real-time Price: $37.84 info
Change: -$19.16 (-34%) info
Market Cap: $2.978B info